Kapin; Michael A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kapin; Michael A..The latest application filed is for "use of monoamine oxidase inhibitors to treat outer retina disorders".

Company Profile

0.8.17

Kapin; Michael A. - Arlington TX
Kapin, Michael A - Arlington TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina Grant 8,710,102 - Collier, Jr. , et al. April 29, 2	2014-04-29
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen Grant 8,158,609 - Marsh , et al. April 17, 2	2012-04-17
Use of Monoamine Oxidase Inhibitors to Treat Outer Retina Disorders App 20110160308 - Collier, JR.; Robert J. ; et al.	2011-06-30
Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina App 20100249134 - Collier, Jr.; Robert J. ; et al.	2010-09-30
Compounds with 5-HT.sub.1A activity useful for treating disorders of the outer retina Grant 7,763,619 - Collier, Jr. , et al. July 27, 2	2010-07-27
Compounds With 5-ht1a Activity Useful For Treating Disorders Of The Outer Retina App 20100168121 - Collier, JR.; Robert J. ; et al.	2010-07-01
Use Of Beta-adrenoceptor Antagonists For The Manufacture Of A Medicament For The Treatment Of Disorders Of The Outer Retina App 20080103211 - Collier, Jr.; Robert J. ; et al.	2008-05-01
Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina App 20060199868 - Collier; Robert J. JR. ; et al.	2006-09-07
Use of .beta.-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina Grant 7,081,482 - Collier, Jr. , et al. July 25, 2	2006-07-25
Use of pde iv inhibitors to treat angiogenesis App 20060014782 - Gamache; Daniel A. ; et al.	2006-01-19
Use of PDE IV inhibitors to treat angiogenesis App 20050277648 - Gamache, Daniel A. ; et al.	2005-12-15
Compounds with 5-HT1A activity useful for treating disorders of the outer retina App 20050256129 - Collier, Robert J. JR. ; et al.	2005-11-17
Method of treating neurodgenerative disorders of the retina and optic nerve head App 20040132773 - Gamache, Daniel A ; et al.	2004-07-08
PDE IV inhibitors to treat angiogenesis App 20040053939 - Gamache, Daniel A. ; et al.	2004-03-18
R-reliprodil for treating glaucoma App 20030212107 - Kapin, Michael A. ; et al.	2003-11-13
Compounds with 5-ht1a activity useful for treating disorders of the outer retina App 20030207890 - Collier, Robert J JR. ; et al.	2003-11-06
Method of treating vascular endothelial growth factor mediated vascular disorders App 20030207941 - Bingaman, David P. ; et al.	2003-11-06
Method of treating neurodegenerative disorders of the retina and optic nerve head Grant 6,638,976 - Gamache , et al. October 28, 2	2003-10-28
Method of treating angiogenesis-related disorders App 20030187072 - Kapin, Michael A. ; et al.	2003-10-02
Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina App 20020193373 - Collier, Jr., Robert J. ; et al.	2002-12-19
Method of treating neurodegenerative disorders of the retina and optic nerve head App 20020049255 - Gamache, Daniel A. ; et al.	2002-04-25
Method of treating angiogenesis-related disorders App 20020037929 - Kapin, Michael A. ; et al.	2002-03-28
Treatment of ischemic disorders of the retina and optic nerve head Grant 6,020,352 - Kapin , et al. February 1, 2	2000-02-01
Use of polyamine antagonists for the treatment of glaucoma Grant 5,710,165 - Kapin , et al. January 20, 1	1998-01-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.